Genetic changes in nasopharyngeal carcinoma

Chinese Medical Journal

Volumn 110, Issue 7, 1997, Pages 548-559

  Lo, Kwok Wai ^a   Huang, Poon Wai Sin Dolly ^a   Lee, Chuen Kwun Joesph ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

CHROMOSOME 3; CHROMOSOME 9; GENETICS; HERPES VIRUS INFECTION; HUMAN; MUTATION; NASOPHARYNX TUMOR; REVIEW; TUMOR SUPPRESSOR GENE; VIROLOGY; VIRUS INFECTION;

CHROMOSOMES, HUMAN, PAIR 3; CHROMOSOMES, HUMAN, PAIR 9; GENES, P53; HERPESVIRIDAE INFECTIONS; HUMANS; MUTATION; NASOPHARYNGEAL NEOPLASMS; TUMOR VIRUS INFECTIONS;

EID: 0031175219     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (83)

1. Huang DP. Epidemiology and aetiology. In: van Hasselt CA, Gibb AG, eds. Nasopharyngeal Carcinoma. Hong Kong: The Chinese University Press, 1991: 23-35.
2. Chan, SH. Aetiology of nasopharyngeal carcinoma. Ann Acad Med, 1990; 19:201.
3. Lu SJ, Day NE, Degos L, et al. Linkage of a nasopharyngeal carcinoma susceptibility locus to the HLA region. Nature 1990; 346:470.
4. Yu MC, Ho JHC, Lai SH, et al. Cantonese-style salted fish as a cause of nasopharyngeal carcinoma : report of a case-control study in Hong Kong. Cancer Res 1986; 46:956.
5. Yu MC, Mo CC, Chong WX, et al. Preserved foods and nasopharyngeal carcinoa: a case-control study in Guangxi, China. Cancer Res 1988; 48:1954.
6. Yu MC, Garabrant DH, Huang TB, et al. Occupational and other non-dietary risk factors for nasopharyngeal carcinoma in Guangzhou, China. Int J Cancer, 1990; 45:1033.
7. Henle G, Henle W. Epstein-Barr virus specific IgA antibodies as outstanding feature of nasopharyngeal carcinoma. Int J Cancer 1976; 17:1.
8. Rickinson AB, Kieff E. Epstein-Barr virus. In: Fields BN, Knipe DM, Howley PM, et al. Fields Virology. Philadelphia Lippincott - Raven Publishers, 1996; 2397-2446.
9. Raab-Traub N, Flynn K. The structure of the termini of the Epstein-Barr virus as a marker of clonal cellular proliferation. Cell 1986; 47:883.
10. Vogelstein B, Kinzler KW. The multistep nature of cancer. Trends Genet 1993; 9:138.
11. Zhang S, Wu Y, Zeng Y, et al. Cytogenetic studies on an epithelioid cell line derived from nasopharyngeal carcinoma. Hereditas 1982; 97:23.
12. Zhang S, Gao X, Zeng Y. Cytogenetic studies on an epithelial cell line derived from poorly differentiated nasopharyngeal carcinoma. Int J Cancer 1983; 31:587.
13. Mitelman F, Mark-Vendel E, Mineur A, et al. A 3q + marker chromosome in EBV-carrying nasopharyngeal carcinomas. Int J Cancer 1983; 32:651.
14. Chang YS, Lin SY, Lee PF, et al. Establishment and characterization of a tumor cell line from human nasopharyngeal carcinoma tissue. Cancer res 1989; 49:6752.
15. Huang DP, Ho JHC, Chan WK, et al. Cytogenetics of undifferentiated nasopharyngeal carcinoma xenografts from southern Chinese. Int J Cancer 1989; 43:963.
16. Kristensen M, Quek HH, Chew CT, et al. A cytogenetic study of 74 nasopharyngeal carcinoma biopsies. Ann Acad Med Singapore 1991; 20:597.
17. Bernheim A, Rousselet G, Massaad L, et al. Cytogenetic studies in three xenografted nasopharyngeal carcinomas. Cancer Genet Cytogenet 1993; 66:11.
18. Lin CT, Chan WY, Chen W, et al. Characterization of seven newly established nasopharyngeal carcinoma cell lines. Lab Invest 1993; 68:716.
19. Waghray M, Parhar RS, Taibah K, et al. Rearrangements of chromosome arm 3q in poorly differentiated nasopharyngeal carcinoma. Genes Chromos Cancer. 1992; 4:326.
20. Hui ABY, Cheung ST, Fong Y, et al. Characterization of a new EBV-associated nasopharyngeal carcinoma cell line. Cancer Genet Cytogenet 1997. (in press)
21. Lo KW, Tsao SW, Leung SF, et al. Detailed deletion mapping on the short arm of chromosome 3 in nasopharyngeal carcinomas. Int J Oncol 1994; 4:1359.
22. Huang DP, Lo KW, van Hasselt CA, et al. A region of homozygous delection on chromosome 9p21-22 in primary na-sopharyngeal carcinoma. Cancer Res 1994; 54:4003.
23. Hui ABY, Lo KW, Leung SF, et al. Loss of heterozygosity on the long arm of chromosome 11 in nasopharyngeal carcinoma. Cancer Res 1996; 56:3225.
24. Cheng RYS, Lo KW, Huang DP, et al. Loss of heterozygosity on chromosome 14 in primary nasopharyngeal carcinoma. Int J Oncology 1997. (in press)
25. Hu LF, Eiriksdottir G, Lebedeva T, et al. Loss of heterozygosity on chromosome 3p in nasopharyngeal carcinoma. Genes chromos cancer, 1996; 17:118.
26. Ohta M, Hiroshi I, Cotticelli MG, et al. The FHIT gene, spanning the chromosome 3p14. 2 fragile site and renal carcinoma -associated t(3;8) breakpoint, is abnormal in digestive tract cancers. Cell 1996; 84:587.
27. Thiagalingam S, Lisitsyn NA, Hamaguchi M, et al. Evaluation of the FHIT gene in colorectal cancers. Cancer Res 1996; 56:2936.
28. Druck T, Hadaczek P, Fu TB, et al. Structure and expression of the Human FHIT gene in normal and tumor cells. Cancer Res 1997; 57:504.
29. Wu CL, Sloan P, Read AP, et al. Deletion mapping on the short arm of chromosome 3 in squamous cell carcinoma of the oral cavity. Cancer Res 1994; 54:6484.
30. Hibi K, Takahashi T, Yamakawa K, et al. Three distinct regions involved in human lung cancer. Oncogene 1992; 7: 445.
31. Maestro R, Gasparotto D, Vukosavljevic T, et al. Three discreet regions of deletion at 3p in head and neck cancers. Cancer Res 1993; 53:5775.
32. Latif F, Tory K, Gnarra J, et al. Identification of the von Hippel-Lindau tumor suppressor gene. Science 1993; 260: 1317.
33. Oberstrass J, Reifenberger G, Reifenberger J, et al. Mutation of the von Hippel-Lindau tumor suppressor gene in capillary haemangioblastomas of the central nervous system. J Pathol 1996; 179:151.
34. Kibel A, Iliopoulos O, DeCaprio JA, et al. Binding of the von Hippel-Lindau tumor suppressor protein to elongin B and C. Science 1995; 269:1444.
35. Sun Y, Hildesheim A, Li H, et al. The von Hippel-Lindau (VHL) disease tumor-suppressor gene is not mutated in nasopharyngeal carcinomas. Int J Cancer 1995; 60:437.
36. Sherr, CJ. Cancer cell cycles. Science 1996; 274: 1672.
37. Sun Y, Hildesheim A, Lanier AEP, et al. No point mutation but decreased expression of the p16/MTS1 tumor suppressor gene in nasopharyngeal carcinomas, Oncogene 1995; 10: 785.
38. Lo KW, Huang DP, Lau KM. p16 gene alterations in nasopharyngeal carcinoma. Cancer Res 1995; 55:2039.
39. Lo KW, Cheung ST, Leung SF, et al. Hypermethylation of the p16 gene in nasopharyngeal carcinoma. Cancer Res 1996; 56:2721.
40. Savitsky K, Bar-Shira A, Gilad S, et al. A single ataxia telangiectasia gene with a product similar to PI-3 kinase. Science 1995; 268:1749.
41. Sun Y, Hegamyer G, Colburn NH. Nasopharyngeal carcinoma shows no detectable retinoblastoma susceptibility gene alterations. Oncogene 1993; 716.
42. Claudio PP, Howard CM, Baldi A, et al. p130/Rb2 has growth suppressive properties similar to yet distinctive from those of retinoblastoma family members pRb and p107. Cancer Res 1994; 54:5556.
43. Levine AJ. p53: the cellular gatekeeper for growth and division. Cell 1997; 88:323.
44. Lo KW, Mok CH, Huang DP, et al. p53 mutation in human nasopharyngeal carcinomas. Anticancer Res 1992; 12: 1957.
45. Spruck CH, Tsai YC, Huang DP, et al. Absence of p53 gene mutations in primary nasopharyngeal carcinomas. Cancer Res 1992; 52:4787.
46. Effert P, McCoy R, Abdel-Hamid M, et al. Alterations of the p53 gene in nasopharyngeal carcinoma. J Virol 1992; 66:3768.
47. Chakrant F, Armand J, Lenoir G, et al. Mutations clustered in exon 5 of the p53 gene in primary nasopharyngeal carcinomas from southeastern Asia. Int J Cancer 1995; 61:316.
48. Porter MJ, Field JK, Lee JCK, et al. Detection of the tumour suppressor gene p53 in nasopharyngeal carcinoma in Hong Kong Chinese. Anticancer Res 1994; 14:1357.
49. Niedobitek G, Agathanggelou A, Barber P, et al. p53 expression and Epstein-Barr virus infection in undifferentiated and squamous cell nasopharyngeal carcinomas. J Pathol 1993; 170:457.
50. Sheu LF, Chen A, Tseng HH, et al. Assessment of p53 expression in nasopharyngeal carcinoma. Human Pathol 1995; 26:380.
51. Sun Y, Hildesheim A, Li H, et al. No point mutation but a codon 31 ser > arg polymorphism of the WAF-1/CIP-1/ p21 tumor suppressor gene in nasopharyngeal carcinoma (NPC): the polymorphism distingushes Caucasians from Chinese. Cancer Epidemiol Biomarkers Prevention 1995; 4:261.
52. Wang Q, Hu LF, Chen F, et al. Infrequent MDM2 gene amplification and absence of gross WAF1 gene alterations in nasopharyngeal carcinoma. Eur J Cancer (Oral Oncol) 1995; 31B:328.
53. Lu QL, Elia G, Lucas S, et al. Bcl-2 proto-oncogene expression in Epstein-Barr virus associated nasopharyngeal carcinoma. Int J Cancer 1993; 53:29.
54. Agathanggelou A, Niedobitek G, Chen R, et al. Ex pression of immune regulatory molecules in Epstein-Barr virus-associated nasopharyngeal carcinoma with prominent lymphoid stroma. Am J Pathol 1995; 147:1152.
55. Harn HJ, Ho LI, Liu CA, et al. Down regulation of bcl-2 by p53 in nasopharyngeal carcinoma and lack of detection of its specific t(14; 18) chromosomal translocation in fixed tissues. Histopathology 1996; 28:317.
56. Porter MJ, Field JK, Leung SF, et al. The detection of the c-myc and ras oncogenes in nasopharyngeal carcinoma by immunohistochemistry. Acta Otolaryngeal (Stockh) 1994; 114: 105.
57. Yung WCW, Sham JST, Choy DTK, et al. ras mutations are uncommon in nasopharyngeal carcinoma. Eur J Cancer (Oral Oncol) 1995; 31B:399.
58. Sun Y. Molecular oncology of human nasopharyngeal carcinoma. Cancer J 1995; 8:325.
59. Hockenbery D, Nunez G, Milliman C, et al. Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell dealth. Nature 1990; 348:334.
60. Yunis JJ, Oken MM, Kaplan ME, et al. Distinctive chromosomal abnormalities in histologic subtypes of non-Hodkin's lymphoma. New Engl J Med 1982; 307:1231.
61. Seto M, Jaeger V, Kockett R, et al. Alternative promoters and exons, somatic mutation and deregulation of the bcl-2-Ig fusion gene in lymphoma. EMBO J 1988; 7:123.
62. Henderson S, Rowe M, Gregory C, et al. Introduction of bcl-2 expression by Epstein-Barr virus latent membrane protein I protects infected B cells from programmed cell death. Cell 1991; 65:1107.
63. Leach FS, Tokino T, Meltzer P, et al. p53 mutation and MDM2 amplification in human soft tissue sarcomas. Cancer Res 1993; 53:2231.
64. Reifenberger G, Liu L, Ichimura K, et al. Amplification and overexpression of the MDM2 gene in a subset of human malignant gliomas without p53 mutations. Cancer Res 1993; 53:2736.
65. Cao Y, Sun Y, Poirer S, et al. Isolation and partial charcaterization of a transformation-associated sequence from human nasopharyngeal carcinoma. Mol Carcinogenesis 1991; 4: 297.
66. Yao KT, Cao Y, Deng XY, et al. Cloning and characterization of the nasopharyngeal carcinoma transforming gene. In: Abstracts of 3rd Hong Kong International Cancer Congress & 7th International EBV Symposium, 1996:48.
67. Autexter C, Greider CW. Telomerase and cancer: revisiting the telomere hypothesis. Trends Biochem Sci 1996; 21: 387.
68. Tsao SW, Cheng RYS, Yuen PW, et al. Telomerase activation in primary and recurrent nasopharyngeal carcinomas (NPC). In : Abstracts of 3rd Hong Kong International Cancer Congress & 7th International EBV Symposium, 1996: H12. 2.
69. Ohmura H, Tahara H, Suzuki M, et al. Restoration of the cellular senescence program and repression of telomerase by human chromosome 3. Jpn J Cancer Res 1995; 86:899.
70. Klingelhutz AJ, Foster SA, McDougall JK. Telomerase activation by the E6 gene product of human papillomavirus type 16. Nature 1996; 380,79.
71. Pathmanathan R, Prasad U, Sadler R, et al. Clonal proliferations of cells infected with Epstein-Barr virus in preinva- sive lesions related to nasopharyngeal carcinoma. N Engl J Med 1995; 333:693.
72. Jiang X, Yao KT. The clonal progression in the neoplastic process of nasopharyngeal carcinoma. Biochem Biophys Res Commun 1996; 221:122.
73. Raab-Traub N, Flynn K. The Structure of the termini of the Epstein-Barr virus as a marker of clonal cellular proliferation. Cell 1986; 47:883.
74. kip1 and cyclin E alone and in combination, correlate with survival in young breast cancer patients. Nature Med 1997; 2:222.
75. Loda M, Cukor B, Tam SW, et al. Increased proteasome-dependent degradation of the cyclin-dependent kinase inhibitor p27 in aggressive colorectal carcinomas. Cell 1997; 2: 231.
76. Hunter T. Oncoprotein Networks. Cell 1997; 88:333.
77. Froes KL, Miller WE, Raab-Traub. Epstein-Barr virus latent membrane protein 1 blocks p53-mediated apoptosis through the induction of the A20 gene. J Virol 1996; 70:8653.
78. Opipari AW Jr, Hu HM, Yabkowitz R, et al. The A20 zinc finger protein protects cells from tumor necrosis factor cytotoxicity. J Biol Chem 1992; 267:12424.
79. Mosialos G, Birkenbach M, Yalamanchili R, et al. The Epstein-Barr virus transforming protein LMP1 engages signaling proteins for the tumor necrosis factor receptor family. Cell 1995; 80:389.
80. Chen XQ, Stroun M, Magnenat JL, et al. Microsatellite alterations in plasma DNA of small cell lung cancer patients. Nature Med, 1996; 2:1033.
81. Nawroz H, Koch W, Anker P, et al. Microsatellite alterations in serum DNA of head and neck patients. Nature Med 1996; 2:1035.
82. Liggett WH Jr, Sewell DA, Rocco J, et al. p16 and p16 beta are potent growth suppressors of head and neck squamous carcinoma cells in vitro. Cancer Res 1996; 56:4119.
83. Spillare EA, Okamoto A, Hagiwara K, et al. Suppression of growth in vitro and tumorigenicity in vivo of human carcinoma cell lines by transfected p16INK4. Mol Carcinog 1996; 16:53.